Data from the Michigan Department of Health and Human Services shows a 34% reduction in overdose deaths between 2023 and 2024.

Fintel reports that on June 6, 2025, Goldman Sachs initiated coverage of Teva Pharmaceutical Industries Limited - Depositary ...

Current Deferiprone market momentum reflects rising transfusion-related iron overload cases, broader regulatory approvals, generic competition loweri ...

Birth control medication is being pulled from Canadian shelves over extra placebo tablets, Health Canada says. The recall ...

Teva Pharmaceutical (TEVA) stock, Amneal Pharma (AMRX) stock receive Buy ratings and Viatris (VTRS) stock receives a Neutral rating at Goldman Sachs. Read more here.

A live webcast of the fireside chat will be available to the general public and can be accessed at ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

The FDA has granted Fast Track designation to TEV-53408, an investigational anti-interleukin-15 antibody, for the treatment of celiac disease.

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival ...

Ireland's government and pharmaceutical sector have broadly welcomed the European Council's 'pharma package' agreement, but opposition remains in Dublin over potential delays to affordable drugs.